Bengaluru-based healthtech startup Acculi Labs has raised ₹5 crore in seed funding from Mumbai-based investment firm PirE Ventures. The startup in September 2019 secured undisclosed pre-seed funding from a group of angels and Bengaluru-based consultancy and services firm Startup Basket. Acculi's flagship product Lyfas is a clinical grade smartphone-based tool used for early diagnostics.